In a bid to have more liquid assets to pay off current liabilities, Nigeria’s largest publicly listed drugmakers have recorded an 89 percent increase in total cash and cash equivalents reported in the first quarter of 2023.
Data sourced from the Nigerian Exchange Group showed that Nigerian drug
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
Folake Balogun
Folake Balogun is a tech journalist covering Africa’s fast-growing digital economy with a strong focus on incisive analysis of startup trends, venture capital, and fintech innovation, while also exploring emerging technologies such as artificial intelligence and the future of connectivity by highlighting their economic and social impact.
